Niagen Bioscience, Inc. (NAGE) Gross profit 2016–2025
Niagen Bioscience, Inc. (NAGE) annual gross profit history from SEC filings — each fiscal year as reported.
$83.2MFY2025 · since FY2016: $10.4M → $83.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $83.2M | +35.1% |
| FY2024 | $61.6M | +21.3% |
| FY2023 | $50.8M | +18.7% |
| FY2022 | $42.8M | +3.2% |
| FY2021 | $41.5M | +17.6% |
| FY2020 | $35.3M | +36.9% |
| FY2019 | $25.8M | +60.5% |
| FY2018 | $16.1M | +53.2% |
| FY2017 | $10.5M | +0.8% |
| FY2016 | $10.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice